Clinical and LAT1 Biomarker Correlates of Clinical Benefit from Nanvuranlat (JPH203) in Advanced Biliary Tract Cancer: A Post Hoc Analysis
- DOI
- 10.3390/cancers18152492
- Published
- 2026-08-04
- Container
- Cancers
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18152492,
title = {Clinical and LAT1 Biomarker Correlates of Clinical Benefit from Nanvuranlat (JPH203) in Advanced Biliary Tract Cancer: A Post Hoc Analysis},
author = {Eric K. Rowinsky and Ghassan K. Abou-Alfa and Junji Furuse and Makoto Ueno and Masafumi Ikeda and Hiroko Tabuchi and Kazuo Sekiguchi and Michael Szarek},
year = {2026},
journal = {Cancers},
doi = {10.3390/cancers18152492},
url = {https://doi.org/10.3390/cancers18152492}
}RIS
TY - JOUR TI - Clinical and LAT1 Biomarker Correlates of Clinical Benefit from Nanvuranlat (JPH203) in Advanced Biliary Tract Cancer: A Post Hoc Analysis AU - Eric K. Rowinsky AU - Ghassan K. Abou-Alfa AU - Junji Furuse AU - Makoto Ueno AU - Masafumi Ikeda AU - Hiroko Tabuchi AU - Kazuo Sekiguchi AU - Michael Szarek PY - 2026 JO - Cancers DO - 10.3390/cancers18152492 UR - https://doi.org/10.3390/cancers18152492 ER -
APA
Rowinsky, E. K., Abou-Alfa, G. K., Furuse, J., Ueno, M., Ikeda, M., Tabuchi, H., Sekiguchi, K., & Szarek, M. (2026). Clinical and LAT1 Biomarker Correlates of Clinical Benefit from Nanvuranlat (JPH203) in Advanced Biliary Tract Cancer: A Post Hoc Analysis. Cancers. https://doi.org/10.3390/cancers18152492
Source records
- crossref · retrieved 2026-09-25T20:20:04.381Z